US 10428133
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted A61PA61P35/00A61P37/02
Quick answer
US patent 10428133 (Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P35/00, A61P37/02